Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.8 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |